K

KMPharmaceutical Co Ltd
KOSDAQ:225430

Watchlist Manager
KMPharmaceutical Co Ltd
KOSDAQ:225430
Watchlist
Price: 528 KRW -2.58% Market Closed
Market Cap: ₩14.7B

KMPharmaceutical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

KMPharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
K
KMPharmaceutical Co Ltd
KOSDAQ:225430
Research & Development
-₩837.2m
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Research & Development
-₩102.3B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Amorepacific Group
KRX:002790
Research & Development
-₩103.8B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Cosmax Inc
KRX:192820
Research & Development
-₩1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Research & Development
-₩21B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
-3%
Kolmar Korea Co Ltd
KRX:161890
Research & Development
-₩30.9B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-36%
No Stocks Found

KMPharmaceutical Co Ltd
Glance View

Market Cap
14.7B KRW
Industry
Consumer products

KMPHARMACEUTICAL Co., Ltd. engages in the development and sale of oral health products. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2015-10-08. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The firm distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.

Intrinsic Value
536.06 KRW
Undervaluation 2%
Intrinsic Value
Price
K

See Also

What is KMPharmaceutical Co Ltd's Research & Development?
Research & Development
-837.2m KRW

Based on the financial report for Sep 30, 2025, KMPharmaceutical Co Ltd's Research & Development amounts to -837.2m KRW.

What is KMPharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-38%

Over the last year, the Research & Development growth was -75%. The average annual Research & Development growth rates for KMPharmaceutical Co Ltd have been -38% over the past three years .

Back to Top